Mifeprex is generally mifepristone, patients taking mifepristone, usually within 24-72 hours after the HCG (human chorionic gonadotropin) can be significantly decreased.
Mifepristone is an anti-early pregnancy drug, which is used in sequential combination with prostaglandin drugs to terminate a pregnancy within 49 days of menopause, and patients generally experience a significant decrease in blood HCG, usually within 24-72 hours after taking mifepristone. Adverse effects of this product may include uterine bleeding, lower abdominal pain, nausea, vomiting, fainting, fatigue, pelvic pain, and anal sensation.
This product should be contraindicated for those who are allergic to the ingredients in this product, patients with heart, liver and kidney diseases, adrenocortical insufficiency, contraindications to prostaglandin drugs such as asthma, glaucoma, etc., pregnancies with intrauterine devices as well as suspected ectopic pregnancies.
Patients should take the drug under the guidance of a doctor, and should not take it privately to avoid adverse consequences.